Insider Transactions in Q1 2025 at Taysha Gene Therapies, Inc. (TSHA)

TSHA Quotes by TradingView

Insider Transaction List (Q1 2025)

Date Insider Transaction Ownership Type Shares Traded Value / Price
Jan 02 2025
Sukumar Nagendran President and Head of R&D
BUY
Grant, award, or other acquisition
Direct
324,500 +20.98%
-
Jan 02 2025
Sean P. Nolan Chief Executive Officer
BUY
Grant, award, or other acquisition
Direct
892,500 +30.04%
-
Jan 02 2025
Kamran Alam CHIEF FINANCIAL OFFICER
BUY
Grant, award, or other acquisition
Direct
431,000 +25.31%
-

Track Institutional and Insider Activities on TSHA

Follow Taysha Gene Therapies, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TSHA shares.

Notify only if

Insider Trading

Get notified when an Taysha Gene Therapies, Inc. insider buys or sells TSHA shares.

Notify only if

News

Receive news related to Taysha Gene Therapies, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TSHA